» Articles » PMID: 21881569

A Randomized Trial on Mineralocorticoid Receptor Blockade in Men: Effects on Stress Responses, Selective Attention, and Memory

Overview
Date 2011 Sep 2
PMID 21881569
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Corticosteroids, released in high amounts after stress, exert their effects via two different receptors in the brain: glucocorticoid receptors (GRs) and mineralocorticoid receptors (MRs). GRs have a role in normalizing stress-induced effects and promoting consolidation, while MRs are thought to be important in determining the threshold for activation of the hypothalamic-pituitary-adrenal (HPA) axis. We investigated the effects of MR blockade on HPA axis responses to stress and stress-induced changes in cognitive function. In a double-blind, placebo-controlled study, 64 healthy young men received 400 mg of the MR antagonist spironolactone or placebo. After 1.5 h, they were exposed to either a Trier Social Stress Test or a non-stressful control task. Responses to stress were evaluated by hormonal, subjective, and physiological measurements. Afterwards, selective attention, working memory, and long-term memory performance were assessed. Spironolactone increased basal salivary cortisol levels as well as cortisol levels in response to stress. Furthermore, spironolactone significantly impaired selective attention, but only in the control group. The stress group receiving spironolactone showed impaired working memory performance. By contrast, long-term memory was enhanced in this group. These data support a role of MRs in the regulation of the HPA axis under basal conditions as well as in response to stress. The increased availability of cortisol after spironolactone treatment implies enhanced GR activation, which, in combination with MR blockade, presumably resulted in a decreased MR/GR activation ratio. This condition influences both selective attention and performance in various memory tasks.

Citing Articles

Mineralocorticoid Receptor Antagonists and Cognitive Outcomes in Cardiovascular Disease and Beyond: A Systematic Review.

Pastena P, Campagnoli G, Rahmani A, Kalogeropoulos A J Pers Med. 2025; 15(2).

PMID: 39997334 PMC: 11856062. DOI: 10.3390/jpm15020057.


Cortisol awakening response prompts dynamic reconfiguration of brain networks in emotional and executive functioning.

Zeng Y, Xiong B, Gao H, Liu C, Chen C, Wu J Proc Natl Acad Sci U S A. 2024; 121(52):e2405850121.

PMID: 39680766 PMC: 11670246. DOI: 10.1073/pnas.2405850121.


Effects of chronic stress on cognitive function - From neurobiology to intervention.

Girotti M, Bulin S, Carreno F Neurobiol Stress. 2024; 33:100670.

PMID: 39295772 PMC: 11407068. DOI: 10.1016/j.ynstr.2024.100670.


Efficacy of spironolactone as adjunctive therapy to sodium valproate in bipolar-I disorder: A double-blind, randomized, placebo-controlled clinical trial.

Zandifar A, Badrfam R, Gholamian F, Shafiee A Brain Behav. 2023; 13(12):e3313.

PMID: 37933420 PMC: 10726882. DOI: 10.1002/brb3.3313.


The Hypothalamus-Pituitary-Adrenal Axis and Social Cognition in Borderline Personality Disorder.

Kulakova E, Graumann L, Wingenfeld K Curr Neuropharmacol. 2023; 22(3):378-394.

PMID: 37539934 PMC: 10845078. DOI: 10.2174/1570159X21666230804085639.


References
1.
Reul J, Stec I, Soder M, Holsboer F . Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology. 1993; 133(1):312-20. DOI: 10.1210/endo.133.1.8391426. View

2.
Deuschle M, Weber B, Colla M, Muller M, Kniest A, Heuser I . Mineralocorticoid receptor also modulates basal activity of hypothalamus-pituitary-adrenocortical system in humans. Neuroendocrinology. 1998; 68(5):355-60. DOI: 10.1159/000054384. View

3.
Lupien S, Maheu F, Tu M, Fiocco A, Schramek T . The effects of stress and stress hormones on human cognition: Implications for the field of brain and cognition. Brain Cogn. 2007; 65(3):209-37. DOI: 10.1016/j.bandc.2007.02.007. View

4.
Tasker J, Di S, Malcher-Lopes R . Minireview: rapid glucocorticoid signaling via membrane-associated receptors. Endocrinology. 2006; 147(12):5549-56. PMC: 3280589. DOI: 10.1210/en.2006-0981. View

5.
Adam E, Sutton J, Doane L, Mineka S . Incorporating hypothalamic-pituitary-adrenal axis measures into preventive interventions for adolescent depression: are we there yet?. Dev Psychopathol. 2008; 20(3):975-1001. DOI: 10.1017/S0954579408000461. View